US stock market today, October 16, surged despite fresh US-China trade tensions. The Dow, S&P 500, and Nasdaq all moved higher. Nvidia, TSM...

U.S. stock market today paused after a week of record gains. Dow Jones fell while the S&P 500 and Nasdaq retreated from all-time highs. Tra...

The US stock market showed mostly small gains today despite a government shutdown. The Dow, S&P 500, and Nasdaq all rose, led by strong tec...

U.S. stock market futures rose today following the Federal Reserve's rate cut, with all three major indexes climbing in early trading. The ...

Despite exceeding Q2 earnings expectations, Coca-Cola's stock experienced a slight dip. Investors are cautiously observing a decline in vol...

Nilesh Shah of Kotak AMC suggests that Indian equities appear promising compared to other emerging markets, with expected earnings growth i...

Healthkart has closed a secondary funding round that values the startup at $500 million. This and more in today’s ETtech Top 5.

We are not here to garner popularity. Our job is to look after client’s money carefully. We have doubled our client’s money net of all fees...

“I feel in terms of time, the pain may be there in the economy for a long time, but I do not think the pain in the market will last more th...

Impatient to return to the campaign trail, President Donald Trump dubiously claimed he's fully recovered and immune from COVID-19, hailed a...

Talking about stocks and sectors, Jhunjhunwala says he is bullish on pharma sector.

Life is not about regrets, life is about learnings, Jhunjhunwala told market veteran Madhu Kela.

It has been a market of deception, a market of distribution, says VC of First Global.

“Like pretty girls, stock markets may excite you but you pay a very heavy price!”

Midcap, smallcaps are doing time and price correction. Pharma and IT are up a little bit.

It’s natural to think that with prosperity and Bollywood becoming more corporatised over the years, there will be a more nuanced take on bu...